2500000
15673
5806
5806
17005
250
2500000
10000000
157131
17005
0.0001
168080
17005
11199
2500000
0.0001
75000000
2500000
250
168080
-157131
0.0001
21767
2500000
250
40000
-18483
4944
2500000
250
52500
-47806
-12921
2500000
250
59500
-72671
-7091
2500000
250
88500
-95841
12934
-2435
2500000
250
113500
-116185
9439
9439
8001
250
2500000
10000000
139188
8001
0.0001
137500
8001
-1438
2500000
0.0001
75000000
2500000
250
137500
-139188
168080
426
-151325
131125
26432
5806
-157131
250
17005
157557
168330
24000
5
-21261
11550
2387
-7329
-13932
2739
13937
24000
-0.01
2500000
Q3
R&R ACQUISITION VIII, INC
false
Smaller Reporting Company
2012
10-Q
2012-03-31
0001368510
--06-30
30580
<div style="FONT: 10pt Times New Roman, Times, Serif">
<p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">
<b>NOTE 4 - Common Stock</b></p>
<p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">
 </p>
<p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">During
the nine months ended March 31, 2012 and 2011, the major
stockholder contributed an additional $30,580 and $24,000,
respectively.</p>
</div>
30580
4
<div style="font: 10pt Times New Roman, Times, Serif">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
<b>NOTE 7 – Commitments and Contingencies</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
On January 29, 2009, the Company entered into an agreement with
Kirk M. Warshaw, LLC (the “LLC”) for the use and
occupancy, and administrative services, related to its principal
offices. The agreement provides for quarterly payments from the
Company to the LLC of $500. The effective date of the agreement was
January 1, 2009.</p>
</div>
-21576
11550
<div style="font: 10pt Times New Roman, Times, Serif">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
<b>NOTE 2 - Basis of Presentation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
The financial statements have been prepared by the Company, without
audit, pursuant to the rules and regulations of the Securities and
Exchange Commission. Certain information and footnote disclosures
normally included in financial statements prepared in accordance
with generally accepted accounting principles have been condensed
or omitted pursuant to such rules and regulations. In the opinion
of management, the accompanying financial statements include all
adjustments (consisting of normal, recurring adjustments) necessary
to make the Company's financial position, results of operations and
cash flows not misleading as of March 31, 2012. The results of
operations for the three and nine months ended March 31, 2012 and
2011, and for the period June 2, 2006 (Date of Inception) to March
31, 2012, are not necessarily indicative of the results of
operations for the full year or any other interim period. These
financial statements should be read in conjunction with the audited
financial statements and notes thereto included in the Company's
Annual Report on Form 10-K for the year ended June 30, 2011.</p>
</div>
6397
-3633
<div style="font: 10pt Times New Roman, Times, Serif">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
<b>NOTE 8 – Subsequent Events</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
The Company has evaluated all subsequent events and has determined
that there were no subsequent events to recognize or disclose in
these financial statements.</p>
</div>
<div style="font: 10pt Times New Roman, Times, Serif">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
<b>NOTE 6 – New Accounting Pronouncements</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
Management does not believe that any new accounting pronouncements
not yet effective will have a material impact on the
Company’s financial statements once adopted.</p>
</div>
-17943
<div style="font: 10pt Times New Roman, Times, Serif">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
<b>NOTE 3 - Summary of Significant Accounting Policies</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
Use of Estimates - The preparation of financial statements in
conformity with accounting principles generally accepted in the
United States of America requires management to make estimates and
assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements and reported amounts of
revenue and expenses during the reporting period. Actual results
could differ from those estimates.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
Fair Value of Financial Instruments - We are required to estimate
the fair value of all financial instruments included on our balance
sheet as of March 31, 2012. We consider the carrying value of
accrued expenses in the financial statements to approximate their
face value.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
Statements of Cash Flows - For purposes of the statements of cash
flows we consider all highly liquid investments purchased with a
remaining maturity of three months or less to be cash
equivalents.</p>
</div>
<div style="font: 10pt Times New Roman, Times, Serif">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
<b>NOTE 1 - Organization, Business and Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
R&R ACQUISITION VIII, INC. (the "Company") was incorporated in
Delaware with the objective to acquire, or merge with, an operating
business. On June 2, 2006, the Company sold 2,500,000 shares of
common stock for $250. As of March 31, 2012, the Company had not
yet commenced any operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
The Company, based on proposed business activities, is a "blank
check" company. The Securities and Exchange Commission defines such
a Company as “a development stage company” that has no
specific business plan or purpose, or has indicated that its
business plan is to engage in a merger or acquisition with an
unidentified company or companies, or other entity or person; and
is issued ‘penny stock,’ as defined in Rule 3a 51-1
under the Securities Exchange Act of 1934, as amended. Many states
have enacted statutes, rules and regulations limiting the sale of
securities of "blank check" companies in their respective
jurisdictions. Management does not intend to undertake any efforts
to cause a market to develop in its securities, either debt or
equity, until the Company concludes a business combination.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
The Company was organized as a vehicle to investigate and, if such
investigation warrants, acquire a target company or business
seeking the perceived advantages of being a publicly held
corporation. The Company’s principal business objective for
the next 12 months and beyond such time will be to achieve
long-term growth potential through a combination with an operating
business. The Company will not restrict its potential candidate
target companies to any specific business, industry or geographical
location and, thus, may acquire any type of business. The analysis
of new business opportunities will be undertaken by or under the
supervision of the officers and directors of the Company.</p>
</div>
9004
<div style="font: 10pt Times New Roman, Times, Serif">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
<b>NOTE 5 – Income Taxes</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
 </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
<font style="font-size: 10pt">Income taxes are accounted for in
accordance with the FASB on, Accounting for Income Taxes. The FASB
requires the recognition of deferred tax assets and liabilities to
reflect the future tax consequences of events that have been
recognized in the Company's financial statements or tax returns.
Measurement of the deferred items is based on enacted tax laws. In
the event the future consequences of differences between financial
reporting bases and tax bases of the Company's assets and
liabilities result in a deferred tax asset, the FASB requires an
evaluation of the probability of being able to realize the future
benefits indicated by such assets. A valuation allowance related to
a deferred tax asset is recorded when it is more likely than not
that some or the entire deferred tax asset will not be
realized.</font> <font style="font-size: 10pt">The deferred tax
asset on the net operating loss carry forward has been offset by a
full valuation allowance.</font></p>
</div>
17947
30580
-0.01
2500000
30580
-17943
40000
-18483
250
2006-06-02
250
2500000
40000
-18483
12500
-29323
12500
-29323
29000
-23170
29000
-23170
25000
-20344
25000
-20344
24000
-23003
24000
-23003
7000
-24865
7000
-24865
3850
801
-4651
4651
0.00
2500000
1
3850
1308
-5157
5158
0.00
2500000
0001368510
2012-01-01
2012-03-31
0001368510
2011-01-01
2011-03-31
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2007-07-01
2008-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2007-07-01
2008-06-30
0001368510
2007-07-01
2008-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2010-07-01
2011-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2010-07-01
2011-06-30
0001368510
2010-07-01
2011-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2009-07-01
2010-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2009-07-01
2010-06-30
0001368510
2009-07-01
2010-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2008-07-01
2009-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2008-07-01
2009-06-30
0001368510
2008-07-01
2009-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2006-07-01
2007-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2006-07-01
2007-06-30
0001368510
2006-07-01
2007-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2006-06-02
2006-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2006-06-02
2006-06-30
0001368510
us-gaap:CommonStockMember
2006-06-02
2006-06-30
0001368510
2006-06-02
2006-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2011-07-01
2012-03-31
0001368510
us-gaap:AdditionalPaidInCapitalMember
2011-07-01
2012-03-31
0001368510
2011-07-01
2012-03-31
0001368510
2010-07-01
2011-03-31
0001368510
2006-06-02
2012-03-31
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2011-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2011-06-30
0001368510
us-gaap:CommonStockMember
2011-06-30
0001368510
2011-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2010-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2010-06-30
0001368510
us-gaap:CommonStockMember
2010-06-30
0001368510
2010-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2009-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2009-06-30
0001368510
us-gaap:CommonStockMember
2009-06-30
0001368510
2009-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2008-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2008-06-30
0001368510
us-gaap:CommonStockMember
2008-06-30
0001368510
2008-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2007-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2007-06-30
0001368510
us-gaap:CommonStockMember
2007-06-30
0001368510
2007-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2006-06-30
0001368510
us-gaap:AdditionalPaidInCapitalMember
2006-06-30
0001368510
us-gaap:CommonStockMember
2006-06-30
0001368510
2006-06-30
0001368510
ck0001368510:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStageMember
2012-03-31
0001368510
us-gaap:AdditionalPaidInCapitalMember
2012-03-31
0001368510
us-gaap:CommonStockMember
2012-03-31
0001368510
2012-03-31
0001368510
2011-03-31
0001368510
2012-04-30
shares
iso4217:USD
iso4217:USD
shares